Inhibition of Chk1-dependent G2 DNA damage checkpoint radiosensitizes p53 mutant human cells
- 8 November 2001
- journal article
- Published by Springer Nature in Oncogene
- Vol. 20 (51) , 7453-7463
- https://doi.org/10.1038/sj.onc.1204942
Abstract
Oncogene is one of the world’s leading cancer journals. It is published weekly and covers all aspects of the structure and function of Oncogenes. Oncogene also publishes 8 Reviews issues a year, on a broad range of topics.Keywords
This publication has 52 references indexed in Scilit:
- Absence of Apparent Phenotype in Mice Lacking Cdc25C Protein PhosphataseMolecular and Cellular Biology, 2001
- DataBase: Research and Evaluation ResultsAmerican Journal of Health Promotion, 2000
- Requirement for p53 and p21 to Sustain G 2 Arrest After DNA DamageScience, 1998
- Development of a Bicistronic Vector Driven by the Human Polypeptide Chain Elongation Factor 1α Promoter for Creation of Stable Mammalian Cell Lines That Express Very High Levels of Recombinant ProteinsBiochemical and Biophysical Research Communications, 1998
- Cdc2 tyrosine phosphorylation is required for the DNA damage checkpoint in fission yeast.Genes & Development, 1997
- Life, death, and the pursuit of apoptosis.Genes & Development, 1996
- Cyclins and cancer II: Cyclin D and CDK inhibitors come of ageCell, 1994
- WAF1, a potential mediator of p53 tumor suppressionCell, 1993
- Human wee1 maintains mitotic timing by protecting the nucleus from cytoplasmically activated cdc2 kinaseCell, 1993
- Universal control mechanism regulating onset of M-phaseNature, 1990